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Abstract 26 
Gastric emptying rate in humans is subject to large individual variability, but previous 27 
research on the influence of genetics is scarce. Variation in the glucagon-like peptide-1 28 
receptor (GLP1R) gene is a plausible candidate gene to partially explain the high 29 
variance. This study aimed to investigate the influence of genetic variation in the 30 
GLP1R gene on gastric emptying rate of a glucose solution in humans. Forty eight 31 
healthy Caucasian males took part in this investigation. Gastric emptying rate of a 6% 32 
glucose solution was assessed using the 13C breath test method and a venous blood 33 
sample was obtained from each participant. Participants were genotyped for twenty-34 
seven Tag single nucleotide polymorphisms (SNPs) in the GLP1R locus using 35 
Sequenom MassARRAY iPLEX GOLD analysis and MALDI-TOF mass spectrometry.  36 
The time at which maximal emptying rate occurred (Tlag) was faster in participants with 37 
the CC genotype than in TT and TC genotypes for SNP rs742764: (Median (quartiles) 38 
CC, 35 (30-36) min vs. TT, 43 (39-46) min and TC, 41 (39-45) min; P < 0.01). Tlag was 39 
also slower in participants with the AA genotype compared to the TT and TA genotypes 40 
for SNP rs2254336: (AA, 43 (39-49) min vs. TT, 36 (34-41) min and TA, 39 (35-42) 41 
min; P < 0.05). Analysis by phenotype also showed differences in half-emptying time 42 
(T½) and Tlag for SNPs rs9283907, rs2268657 and rs2254336. Several neighbouring Tag 43 
SNPs within the GLP1R gene were found to be associated with gastric emptying rate, 44 
and should be further investigated.  45 
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Introduction 47 
An increasing number of genetic variants within the genes coding for gastrointestinal 48 
hormones and their receptors are being found to be associated with obesity phenotypes, 49 
appetite and food regulation. As many of the gastrointestinal hormones involved in 50 
appetite regulation also play a role in the regulation of gastric emptying, it is possible 51 
that genetic variations in gastrointestinal hormones associated with obesity may affect 52 
gastric emptying rate. However, research on the potential influence of genetics on 53 
gastric emptying rate is scarce. Acosta et al. (2014) reported a common genetic variant 54 
rs17782313 in the Melanocortin 4 receptor (MC4R) gene, which has previously been 55 
found to be strongly associated with common obesity (Loos et al., 2008; Vogel et al., 56 
2011), to be associated with reduced gastric emptying rate and satiation. In addition, 57 
Cremonini et al. (2005) found an association between the 779T>C polymorphism in the 58 
cholecystokinin (CCK) gene and slower gastric emptying rate. On the other hand, Jones 59 
et al. (2010) found no effect of common genetic polymorphisms of the CCK or CCK-1 60 
receptor genes on gastric emptying rate.  61 
Genetic variation within a gene related to the action of the gastrointestinal 62 
hormone glucagon-like peptide-1 (GLP-1) presents a plausible area of investigation, as 63 
GLP-1 has been shown to influence gastric emptying rate (Wettergren et al., 1993; 64 
Wishart et al., 1998). Furthermore, large inter-individual variations in gastric emptying 65 
rate of a glucose solution as well as the large differences in GLP-1 hormone responses 66 
to carbohydrate ingestion have been observed (Yau et al., 2014; Yau et al., 2017). GLP-67 
1 exerts its effects via a G-protein coupled receptor called the GLP-1 receptor (GLP1R). 68 
Stimulation of this receptor by GLP-1 triggers cAMP production as the primary signal 69 
transduction pathway (Mayo et al., 2003). The GLP1R recognises GLP-1 specifically 70 
despite the hormone having strong sequence homology to other hormones within the 71 
glucagon-related family of peptides, and furthermore, does not bind to a number of 72 
other related peptides, including secretin (Fehmann et al., 1994). 73 
Genetic polymorphisms of the GLP1R gene have previously been investigated 74 
in relation to insulin secretion (Sathananthan et al., 2010) and the pathogenesis of 75 
diabetes (Tanizawa et al., 2004; Tokuyama et al., 2004; Beinborn et al., 2005). Only 76 
one study has previously investigated the influence of GLP1R genetic variation on 77 
gastric emptying rate, but in mice (Kumar et al., 2008). The presence of a 78 
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nonsynonymous cysteine to tyrosine substitution at amino acid 416 of the GLP1R gene 79 
found in CAST strain mice was associated with reduced GLP1R expression and 80 
significantly faster (by 20%) gastric emptying rate compared to B6 strain mice. This 81 
was also seen for the congenic strains where gastric emptying rate was significantly 82 
higher in B6.CAST-17 congenic mice compared to homozygous B6 controls. 83 
Furthermore, administration of the GLP1R antagonist extendin-(9-36) resulted in no 84 
increase in gastric emptying rate compared to a 10% increase in the homozygous B6 85 
control mice. The GLP1R gene is therefore a plausible candidate gene for a genetic 86 
association study on gastric emptying rate in humans. The human GLP1R gene consists 87 
of 13 exons interrupted by 12 introns (Wilmen et al., 1998) and is situated on 88 
chromosome 6, band p21.1 (Stoffel et al., 1993). A major transcription start point and a 89 
minor transcription start point 42 base pairs (bp) and 360 bp upstream of the translation 90 
initiation site, respectively, have been reported (Lankat-Butgereit & Goke, 1997). Three 91 
putative Sp1 binding sites have also been located in the proximal 5’ flanking sequence 92 
at -108, -173 and -389 bp from the translation initiation codon (Lankat-Butgereit & 93 
Goke, 1997). The receptor is 463 amino acids in length and is highly conserved between 94 
species with 90% being identical to rat GLP1R (Dillon et al., 1993) and approximately 95 
95% homology with mice GLP1R. The primary aim of this study was to investigate the 96 
influence of genetic variation in the GLP1R gene on gastric emptying rate of a glucose 97 
solution in humans.   98 
 99 
Methods 100 
Ethical approval 101 
Forty eight British and South-Western European Caucasian males aged 18-35 years 102 
(mean ± SD, age 23 ± 5 y, height 178 ± 7 cm, body mass 75.8 ± 11.2 kg, body mass 103 
index 23.9 ± 3.3 kg.m-2, and estimated body fat percentage 19 ± 6%) volunteered for 104 
this study. All participants were non-smokers, were not taking medication with any 105 
known effect on gastrointestinal function, and had no known history of chronic 106 
gastrointestinal disease or other medical conditions as assessed by a medical screening 107 
questionnaire. All participants provided written informed consent prior to participation. 108 
The study was granted prior ethical approval from the Manchester Metropolitan 109 
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University Ethical Advisory committee and was performed in accordance with the 110 
Declaration of Helsinki (2008). 111 
 112 
Experimental trial 113 
All participants attended the laboratory for one experimental trial. In the 24 hours 114 
preceding the trial, participants were requested to refrain from alcohol and caffeine 115 
consumption, and the performance of strenuous physical activity. Participants arrived at 116 
the laboratory in the morning following an overnight fast from 2100 h, with the 117 
exception of drinking 500 mL of water 90 minutes prior to arrival at the laboratory, in 118 
an attempt to ensure a consistent and adequate hydration status.  119 
Upon arrival at the laboratory, participants were asked to completely empty their 120 
bladder. Body mass was then recorded. Following this, a whole blood sample was 121 
obtained by venepuncture of an antecubital vein. Once this procedure was completed, 122 
participants ingested 595 mL of a 6% glucose solution as quickly as they were 123 
comfortably able over a maximum period of two minutes. Test solutions were prepared 124 
fresh on the morning of the trial containing 39.6 g glucose monohydrate 125 
(MyProtein.com) dissolved in water and made up to a volume of 600 mL. In addition, 126 
solutions contained 100 mg of 13C sodium acetate (Cambridge Isotopes Laboratories, 127 
Inc., Andover MA, USA) for the assessment of gastric emptying rate. The drink was 128 
served at ambient temperature and a 5 mL sample retained for later analysis of 129 
osmolality. Participants remained seated throughout a 60 minute post-ingestion 130 
sampling period where end expiratory breath samples were collected at baseline then 131 
every 10 minutes after ingestion into foil bags (Wagner Analyzen-Technik, Breman, 132 
Germany) by exhalation through a mouthpiece. Bags were then sealed with a plastic 133 
stopper and stored for later analysis. Breath samples were analysed for the ratio of 134 
13CO2 to 
12CO2 by non-dispersive infrared spectroscopy, with the difference in the ratio 135 
from baseline to post-breath samples expressed as delta over baseline (DOB). Half 136 
emptying time (T½) and the time at which maximal emptying rate occurred (Tlag) were 137 
calculated using the manufacturer’s integrated software evaluation embedded with 138 
equations previously described (Ghoos et al., 1993). Each participant’s own 139 
physiological CO2 production assumed as 300 mmol CO2 per m
2 body surface per hour 140 
was set as default and body surface area was calculated by the integrated software 141 
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according to a previously described formula (Haycock et al., 1978). Following all 142 
sample collections at 60 min, participants were free to leave the laboratory. 143 
 144 
Genotyping 145 
Genomic DNA was extracted from three millilitres of whole blood using Flexigene 146 
DNA Kit (Qiagen, West Sussex, UK), according to the manufacturer’s instructions, 147 
except for the final step of resuspension in 300 μl of nuclease-free ultrapure water. 148 
Extracted DNA was subsequently quantified using a NanoDrop 2000 (Thermo 149 
Scientific, 116 Loughborough, UK) and normalised to a concentration of 40 ng/μl then 150 
stored at -20ºC before working concentrations of 20 ng/μl were prepared in 96 well 151 
plate format prior to use.  152 
Twenty-eight tag single nucleotide polymorphisms (SNPs) in the GLP1R locus 153 
incorporating 10,000 bp upstream and downstream of the major transcription initiation 154 
site and the last exon, respectively, (Chr6: 39114595.…39173498) were selected from 155 
HapMap (www.hapmap.org -HapMap Data release 27 / phase II+III, Feb09, on NCBI 156 
B36 assembly, dbSNP b126). The Tagger algorithm for multi-marker tagging with r2 > 157 
0.8 and minor allele frequency > 0.1 was used [23]. Furthermore, three additional 158 
nonsynonymous SNPs were selected based on previous literature. One of two SNPs 159 
found to be associated with insulin secretion in response to exogenous infusion of GLP-160 
1 by Sathananthan et al. (2010), which was not already in the generated list of 28 tag 161 
SNPs was genotyped. The other two additional SNPs genotyped were two in very close 162 
proximity (two amino acids upstream and three amino acids downstream) to the 163 
equivalent locus of the SNP found in mice to be associated with gastric emptying rate 164 
(Kumar et al., 2008). All 31 SNPs were genotyped using Sequenom MassARRAY 165 
iPLEX GOLD analysis. Forward and reverse primers as well as extension probes were 166 
designed using Sequenom Assay Design Suite (v1.0) which produced two appropriate 167 
assay plexes; plex one containing 24 SNPs and plex two containing 7 SNPs (Table 1). 168 
Primers were purchased from Metabion International AG (Martinsreid, Germany).  169 
Briefly, an initial locus-specific amplification was performed using polymerase 170 
chain reaction (PCR; GeneAmp PCR System 9700, Applied Biosystems) carried out in 171 
a total volume of 5 μl containing 40 ng of DNA and final concentrations of 1.25x 172 
buffer, 1.0 mM MgCl2, 500 μM dNTP mix, 100 nM of each forward and reverse 173 
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primers and 0.1 U/μL Hotstart Taq. PCR conditions consisted of an initial denaturing 174 
step at 94°C for 5 min, followed by 40 cycles of denaturing at 94°C for 20 sec, 175 
annealing at 56°C for 30 sec and extension at 72°C for 1 min and then a final extension 176 
step at 72°C for 3 min. Unincorporated dNTPs within the PCR products were 177 
dephosphorylated by incubationfor 40 min at 37°C followed by 5 min at 85°C with 2µl 178 
Shrimp Alkaline Phosphatase (SAP) mixture composed of 1.7 μl 1x hME buffer and 0.3 179 
μl SAP  1.7 U/μl. A single base extension step was then performed with the addition of 180 
2 μl reaction mix containing 50 μM of each ddNTP, 3.3 μM:6.6 μM extension probe 181 
from low:high mass (2.8 μM:5.6 μM for plex 2), 1.0x buffer and 1.25 U Thermo 182 
Sequenase. Probe extension conditions consisted of a two-step 200 short cycle program 183 
involving initial denaturing at 94°C for 30 s, 40 cycles of denaturing at 94°C for 5 s, 184 
annealing at 52°C for 5 s and extension at 80°C for 5 s where the annealing and 185 
extension steps also cycled 5 times, before a final extension at 72°C for 3 min. 186 
Resulting products were diluted with 20 μl nuclease-free ultrapure water and desalted 187 
with 6 mg resin by gentle inversion for 10 min before centrifugation at 4000 rpm for 5 188 
min. Products were subsequently nano-dispensed (Samsung Sequenom MassARRAY 189 
Nanodispenser) onto a 384-element SpectroCHIP II bioarray and analysed by MALDI-190 
TOF mass spectrometry. 191 
 192 
Data and Statistical analysis 193 
Genotype results were visually checked and appropriate manual genotype assignment 194 
was made upon spectrum inspection where no automated genotype calling had 195 
successfully taken place. Differences in gastric emptying T½ and Tlag were examined 196 
between genotype and phenotype groups. For each SNP analysed, it was hypothesised 197 
that there was a significant difference in gastric emptying rate between genotype groups 198 
or phenotype groups. Normality tests indicated that the majority of data were not 199 
normally distributed. Furthermore, as group sizes were unequal, non-parametric 200 
statistical analysis comprising Kruskal-Wallace and Mann-Whitney U tests were 201 
utilised accordingly. Where appropriate, post-hoc tests of Mann-Whitney U with 202 
Bonferroni correction were applied. All data were analysed using SPSS Statistics for 203 
Windows (IBM, New York, US). Statistical significance was accepted at the 5% level 204 
and results presented as median and quartiles unless stated otherwise. 205 
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 206 
Results 207 
SNP genotyping 208 
Twenty-seven of the 31 SNPs were successfully analysed for variants. No variants 209 
occurred amongst the participants for three SNPs, Tag SNP 3 within the promoter 210 
region (rs9296274) and two of the three selected missense polymorphism, SNPs 24 211 
(rs199796313) and 25 (rs200691429). Genotyping failed in all participants for SNP 13 212 
(rs3765467), one of the three additional missense SNPs. The occasional failure to 213 
successfully genotype one participant occurred in five SNPs, reducing the total 214 
participant number (n) to 47 instead of 48. Frequencies of each genotype are shown in 215 
Table 2. 216 
 217 
Gastric emptying rate 218 
Mean ± SD gastric emptying rate for all participants was 68 ± 16 min and 41 ± 8 min 219 
for T½ and Tlag, respectively. Median (quartiles) gastric emptying rate for all participants 220 
was 63 (55-78) min and 40 (36-44) min for T½ and Tlag, respectively. 221 
 222 
By genotype 223 
Results for Tlag and T½ according to genotype are shown in Table 3 and Table 4, 224 
respectively. Differences in median gastric emptying Tlag was seen for SNP 10 rs742764 225 
and SNP 11 rs2254336. For SNP 10 rs742764, gastric emptying Tlag was faster in 226 
genotype CC compared to genotype TT (P = 0.006) and TC (P = 0.006) by 15%. T½ 227 
was also tending to significance with differences of 18% (P = 0.061). For SNP 11 228 
rs2254336, gastric emptying Tlag was slower in genotype AA compared to genotype TT 229 
(P = 0.04) and TA (P = 0.036) by 19% and 10%, respectively. T½ showed a slight trend 230 
to be slower than both other groups by 20% and 15% but this did not reach statistical 231 
significance (P = 0.138). No significant differences in gastric emptying rate were seen 232 
between genotypes for all other SNPs, although T½ tended toward significance for SNP 233 
9 rs9283907 (P = 0.054) and Tlag tended to significance for SNP 5 rs2268657 (P = 234 
0.087) and SNP 15 rs7766663 (P = 0.076). 235 
 236 
By phenotype 237 
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Results for Tlag and T½ according to phenotype are shown in Table 5 and Table 6, 238 
respectively. A significant effect of the minor allele on median gastric emptying T½ was 239 
seen for SNP 9 rs9283907. Participants with one or two A alleles had faster T½ than 240 
participants homozygous for the allele G by 18% (P = 0.033). A significant effect of the 241 
minor allele on median gastric emptying Tlag was also seen for SNP 5 rs2268657 and 242 
SNP 11 rs2254336. Participants with one or two G alleles had slower Tlag than 243 
participants homozygous for the allele A by 11% (P = 0.028), and participants with one 244 
or two T alleles had faster Tlag than participants homozygous for the allele A by 13% (P 245 
= 0.012), respectively. No differences in gastric emptying rate were seen between 246 
phenotypes for all other SNPs, though T½ tended toward significance for SNP 11 247 
rs2254336 (P = 0.055) and SNP 15 rs7766663 (P = 0.097). 248 
 249 
Body mass index and body fat percentage 250 
Median (quartiles) BMI for all participants was 23.1 (21.6-25.3) kg.m-2. No effect of 251 
genotype on BMI was found for all SNPs although SNP 15 rs7766663 tended to 252 
significance (GG, 24.5 (21.6-26.2) kg.m-2 vs. GT, 24.0 (22.2-26.0) kg.m-2 vs. TT, 22.1 253 
(21.1-23.3) kg.m-2; P = 0.091). Analysis by phenotype, however, revealed median BMI 254 
was significantly higher in participants with one or two minor alleles compared to 255 
homozygotes of the major allele for SNP 12 rs910163 (TT, 22.2 (21.3-24.2) kg.m-2 vs. 256 
CC/CT, 24.6 (22.6-26.7) kg.m-2; P = 0.039) and SNP 15 rs7766663 (TT, 22.1 (21.1-257 
23.3) kg.m-2 vs. GG/GT, 24.0 (22.1-26.3) kg.m-2; P = 0.028).  258 
Median (quartiles) body fat for all participants was 18.3 (14.1-22.2)%. No effect 259 
of genotype nor phenotype was seen for any SNPs, although SNP 28 rs9296291 tended 260 
to significance for phenotype (TT, 17.2 (13.5-19.7)% vs. CC/CT, 20.8 (15.5-24.9)%; P 261 
= 0.061). 262 
 263 
Discussion 264 
The results of this study showed several Tag SNPs of the GLP1R gene are significantly 265 
associated with the gastric emptying rate of a glucose solution in healthy young 266 
Caucasian men. Two neighbouring polymorphisms, SNPs 10 rs742764 and 11 267 
rs2254336, were found to be significantly associated with gastric emptying rate by 268 
genotype. In addition SNPs 5 rs2268657, 9 rs9283907 and 15 rs7766663 tended to 269 
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significance. Furthermore, three SNPs, 5 rs2268657, 9 rs9283907, and 11 rs2254336, 270 
were found to be significantly associated with gastric emptying rate by phenotype. SNP 271 
15 rs7766663 also tended to significance. Thus, significant associations between genetic 272 
variation and gastric emptying rate were found for four Tag SNPs by one or more 273 
measures of genetic association. Tag SNP 5 rs2268657 is situated in intron one and the 274 
other three 9, 10, 11 are situated in intron three.  275 
 The aforementioned Tag SNPs identified to be associated with gastric emptying 276 
rate signify a region where a causative variant is most likely to reside (Xia & Grant, 277 
2013). As three of the associated SNPs are neighbouring Tag SNPs, this presents a 278 
genomic region that warrants further investigation with particularly high interest. 279 
Approximately 3000 bp exist between the locations of SNP 9 rs9283907 and 10 280 
rs742764 and similarly between SNP 10 rs742764 and 11 rs2254336. Spanning this 281 
whole 6132 bp ‘hot spot’ region, a total of 129 SNPs have been sequenced to date. No 282 
known functional SNPs within the GLP1R gene have currently been identified within 283 
this particular region or within introns 1, 3 or 5. However, it is widely known that SNPs 284 
in regulatory elements residing within intronic regions can alter silencing, enhancer, or 285 
splicing events (Chorev & Carmel, 2012; Lee et al., 2012).  Further work by in silico 286 
analysis or multi-array analysis of all 129 known SNPs within this region to narrow 287 
down on the precise SNP or SNPs responsible for the observed differences in gastric 288 
emptying rate should therefore be conducted. The genetic variants surrounding SNP 5 289 
rs2268657 in intron one should also be further investigated as SNPs within intron one of 290 
several genes have been shown to influence gene transcription events (Berulava & 291 
Horsthemke, 2010; Murani et al., 2009).  292 
 Variants in the proximity of SNP 15 rs7766663 also provide a directive area of 293 
further research in gastric emptying regulation as it tended toward significance but was 294 
also significantly associated with BMI by phenotype. This association may signal a link 295 
between gastric emptying rate and BMI but further participants are required to confirm 296 
these concurrent associations. Indeed, further potential ‘links’ or associations may also 297 
be identified with a much larger sample size which will increase the power of future 298 
studies.  299 
  The two additional missense SNPs in close proximity to the locus of the variant 300 
seen in the mice model by Kumar et al., (2008) did not show any variants in the sample 301 
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population of this present study. It may be that the variant is rare or non-existent in the 302 
Caucasian population. The minor allele frequency (MAF) for these two missense SNPs 303 
are unknown. The other additional missense SNP selected for its previous association 304 
with insulin secretion (Sathananthan et al., 2010) also showed no variants in this 305 
participant group. This was mostly likely due to its small MAF of 0.0646 indicating the 306 
SNP is somewhat rare. Tag SNPs 6 rs13202369 and 14 rs6923761, located in intron one 307 
and exon five, respectively, have previously been reported to alter insulin secretion 308 
responses to intravenous GLP-1 (Vella et al., 2009; Sathananthan et al., 2010). These 309 
were not found to be associated with gastric emptying rate in this study, however.  310 
 In conclusion, the results of this targeted gene study to investigate the potential 311 
influence of GLP1R genetic variation on gastric emptying rate in humans revealed 312 
several Tag SNPs to be associated with gastric emptying rate of a glucose solution in 313 
healthy Caucasian men. This suggests that genetic variation within the GLP1R gene 314 
may influence gastric emptying rate in humans. Further work should be undertaken to 315 
identify the precise SNP or SNPs responsible and functional analysis conducted. In 316 
addition, this experiment should be replicated with the use of foods more representative 317 
of a typical meal. Furthermore, this association study should be repeated with a larger 318 
population sample to independently confirm the detected associations between GLP1R 319 
genetic variation and gastric emptying rate.  320 
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Table 1. List of SNPs analysed and primers used. 
 SNP ID Pos. from major 
transcription site (bp) 
Forward primer Reverse primer Extension probe 
1 rs7738586 -9,033 ACGTTGGATGACACCCAGACTGACGTTATC ACGTTGGATGTTGTGCAAAAGCAGCCCAAG TCAAAGTGATTGTCACCATAAG 
2 rs9380825 -5,610 ACGTTGGATGTGAGCCAGGAAGTGATGTTC ACGTTGGATGTCTCATCCAGGCAGCAAGTA cccCTGCACCAGAGCCCCT 
3 rs9296274 -1,455 ACGTTGGATGTTTGGATATCGTGGCTGGAG ACGTTGGATGTGCCTGGGTCTTCTAGCTTC gggtGTGGAAATCTTGGACCA 
4 rs926674 2,930 ACGTTGGATGACTCACACATACCTGGGAAC ACGTTGGATGATACAGACAGGTAGTCTGAG tagcAGGGAGTAGGCTATATGA 
5 rs2268657 3,969 ACGTTGGATGGTTCTGCCGTCCATAAAATG ACGTTGGATGTACAGGGCTTGAGAAGTCAC ggaagTGGGCATATCATTCTTCTCA 
6 rs13202369 6,125 ACGTTGGATGTGATCCACCAGGACTTGCTC ACGTTGGATGTAACAGCTGCAAAGGTGTTG gacaTCCTCAGCTGTGGCTAAT 
7 rs3799707 6,937 ACGTTGGATGTTTGGTTGCTGTGTCAGAGG ACGTTGGATGGCACTCACTTACAGATGCAC AGATGCACTCAACACA(Inosine)C 
8 rs10305432 7,057 ACGTTGGATGTCTTTGTAGCCCTGAACGCC ACGTTGGATGAGTCCTTCAGATCAGTGACC CCGCACACCTTGCGA 
9 rs9283907 10,130 ACGTTGGATGGCTCCTATCATCACACCTTG ACGTTGGATGCCAGAGCATAACCTCATGCC aagaA(Inosine)CAACTGGCCCAGAA 
10 rs742764 13,261 ACGTTGGATGTCTCAGCTTCTGCATCTGTA ACGTTGGATGTGTGGAGAGCTGCTCATGAA ggagcGCTGCTCATGAATCCATTA 
11 rs2254336 16,262 ACGTTGGATGCTGGTCTAAAAGGAGTACAC ACGTTGGATGAAGGTAGGAGCTGGGTATTC ggAGGCTGCATACGACCA 
12 rs910163 16,847 ACGTTGGATGTGAGCCTCAGCCCAGAATAG ACGTTGGATGCAGGGATAGCCCTCAGAATG tATGGGGAGGAAGGGG 
13 rs3765467* 17,022 ACGTTGGATGAACCCCGCCTCAACTCACTC ACGTTGGATGTGCAGAAGGACAACTCCAGC AACTCACTCT(Inosine)TCCCCT 
14 rs6923761 17,499 ACGTTGGATGTTCTCTGCTCTGGTTATCGC ACGTTGGATGGAGTTAGGATGAAGCAGCCC GGGCCACCTTACCTGAAGC 
15 rs7766663 19,209 ACGTTGGATGAGCAATAGGTCTGCATGTGG ACGTTGGATGCTGGTCTCCAATCTCTGGC CCTAGCTAATTGAGAGGC 
16 rs932443 25,761 ACGTTGGATGGTGAATGAAGGAGTGGCAAG ACGTTGGATGTCCTCCCTAATCTGCCATTG ggattGTGTGGAACAGGAAAACTC 
17 rs2268646 26,943 ACGTTGGATGCCAACTGTGTCAGAGTCCTA ACGTTGGATGGTGATGCCAGGAGGCCTTG cccaTTCCACTTGCACATGAA 
18 rs2300614 32,400 ACGTTGGATGTCCAAACCTAGGGCAGGTTC ACGTTGGATGCCCTGCTAAAATTCTTATTTC TCTTTCTGATCTTCAGTGTT 
19 rs2268641 33,693 ACGTTGGATGCTGGGTCCTCTAAGACCTGT ACGTTGGATGCAAAGAGTGGCCCATAAATG ggggAAGACCTGTCCCAGGA 
20 rs2268640 33,811 ACGTTGGATGTGCACTTCCTCGTTTGCATC ACGTTGGATGTCCTCCTCCACTGCCATATC CACTGCCATATCCTCAAAATGA 
21 rs2268639 34,049 ACGTTGGATGGATAGAGAAGTGAGAAACGG ACGTTGGATGATGAGGAGCAGAGGCCTGTA ggcaCTGCTGCCACCTTGTCATCT 
22 rs2206942 34,866 ACGTTGGATGAATTGGGAAGCTCATTCACC ACGTTGGATGGGCAAGTCATTTTGCCTCCC ggcGCTCATTCACCTTCATTTAC 
23 rs2894420 36,523 ACGTTGGATGAACAGGGATCCTGGCTGAC ACGTTGGATGAGTGAGGGCTTCTCAACTG CACTGCAGTGTCTCTCT 
24 rs199796313† 37,124 ACGTTGGATGTCCTTTTCCCATGGAAGGTC ACGTTGGATGTGGATGTGCAAGTGCTCAAG GGTCCAGCTGGAATTT 
25 rs200691429† 37,140 ACGTTGGATGAAGGTCCAGCTGGAATTTCG ACGTTGGATGTGGATGTGCAAGTGCTCAAG gGGAAGAGCTGGGAGC 
26 rs4714211 39,117 ACGTTGGATGAAGGCACCCCTTATTTGCTG ACGTTGGATGACTTGCACCAGCACTGTTTC ccccTTTGCTGTCTCTTCGT 
27 rs10305525 39,577 ACGTTGGATGAATGGCACTGCACTCTTTCC ACGTTGGATGCATTGCATTCAATAGTTCCC aATTCAATAGTTCCCAGACCT 
28 rs9296291 40,356 ACGTTGGATGGATGGTGAAAGTGTCATCTC ACGTTGGATGAAGACAAGGATGAATGAAG gTGAATGAAGTACCAGTGT 
29 rs9968886 43,905 ACGTTGGATGACAGTGAGGTTTTCCCCATC ACGTTGGATGTCATGTAGTCCAGCTTGTGC GCTTGTGCTGCTAGTT 
30 rs2143733 44,923 ACGTTGGATGCATCTAATCGATGGGTAGC ACGTTGGATGCAGAACCCTTCTGAACCTTC GAAATTGAATTTACAGCTTTAATAAA 
31 rs9296292 46,417 ACGTTGGATGTCACAATATGTTTGGCACTG ACGTTGGATGGCTTTGTTTTGCAGAGCTTG TGGCACTGCCAAACT 
 Unshaded SNPs analysed in plex 1, shaded SNPs in plex 2. 
*Additional missense SNP associated with insulin secretion in response to exogenous infusion of GLP-1 by Sathananthan et al. (2010) 
†Additional missense SNPs in close proximity to equivalent SNP associated with gastric emptying rate in mice (Kumar et al., 2008). 
 
 20 
Table 2. SNP genotype frequencies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Genotype 
  
SNP ID 
Homozygous minor 
allele 
 
Heterozygous 
 Homozygous major 
allele 
  
Genotype n Genotype n  Genotype n  Total 
1 rs7738586 AA 0  CA 10  CC 38  48 
2 rs9380825 AA 5  AG 28  GG 15  48 
4 rs926674 TT 3  TC 6  CC 39  48 
5 rs2268657 GG 9  AG 27  AA 11  47 
6 rs13202369 GG 2  AG 21  AA 25  48 
7 rs3799707 TT 3  GT 19  GG 26  48 
8 rs10305432 CC 3  CT 19  TT 26  48 
9 rs9283907 AA 1  AG 9  GG 38  48 
10 rs742764 CC 8  TC 25  TT 14  47 
11 rs2254336 TT 9  TA 23  AA 16  48 
12 rs910163 CC 3  TC 18  TT 27  48 
14 rs6923761 AA 7  GA 28  GG 13  48 
15 rs7766663 GG 10  GT 23  TT 15  48 
16 rs932443 GG 5  AG 21  AA 22  48 
17 rs2268646 AA 0  AG 10  GG 38  48 
18 rs2300614 TT 5  CT 21  CC 22  48 
19 rs2268641 AA 4  AG 21  GG 22  47 
20 rs2268640 CC 3  TC 18  TT 27  48 
21 rs2268639 TT 3  TA 22  AA 22  48 
22 rs2206942 AA 6  AG 24  GG 18  48 
23 rs2894420 AA 9  AG 27  GG 11  47 
26 rs4714211 GG 7  AG 27  AA 13  47 
27 rs10305525 AA 0  CA 9  CC 39  48 
28 rs9296291 CC 3  TC 17  TT 28  48 
29 rs9968886 AA 0  GA 12  GG 36  48 
30 rs2143733 GG 7  GT 27  TT 14  48 
31 rs9296292 CC 4  CT 20  TT 24  48 
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Table 3. Gastric emptying Tlag results according to genotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SNP ID 
Homozygous Minor Allele  Heterozygous  Homozygous Major Allele P-value 
Genotype Median Quartiles  Genotype Median Quartiles    Genotype    Median     Quartiles       
1 rs7738586 --- -- --  CA 37 34-41  CC 40 37-45 0.274 
2 rs9380825 AA 42 61-80  AG 41 37-45  GG 37 36-40 0.349 
4 rs926674 TT 37 37-41  TC 38 36-40  CC 41 36-46 0.448 
5 rs2268657 GG 42 37-44  AG 38 37-46  AA 37 34-39 0.087 
6 rs13202369 GG 34 31-36  AG 41 37-49  AA 39 36-42 0.295 
7 rs3799707 TT 42 36-43  GT 40 35-43  GG 40 37-45 0.696 
8 rs10305432 CC 36 35-37  CT 41 39-43  TT 40 35-46 0.267 
9 rs9283907 AA 29 29-29  AG 37 35-41  GG 41 37-44 0.158 
10 rs742764 CC 35* 30-36  TC 41 39-45  TT 41 37-46 0.008 
11 rs2254336 TT 36 34-41  TA 39 35-42  AA 43† 39-49 0.031 
12 rs910163 CC 37 37-39  TC 40 36-45  TT 41 36-44 0.788 
14 rs6923761 AA 43 41-48  GA 40 37-43  GG 37 34-41 0.222 
15 rs7766663 GG 36 31-40  GT 40 38-44  TT 42 37-48 0.076 
16 rs932443 GG 37 36-41  AG 40 38-45  AA 41 35-44 0.634 
17 rs2268646 -- -- --  AG 40 37-48  GG 40 35-43 0.493 
18 rs2300614 TT 36 35-37  CT 40 37-44  CC 42 36-46 0.210 
19 rs2268641 AA 37 37-38  AG 40 35-44  GG 41 35-44 0.724 
20 rs2268640 CC 37 37-39  TC 40 34-45  TT 41 37-44 0.741 
21 rs2268639 TT 37 37-39  TA 40 35-44  AA 41 36-44 0.816 
22 rs2206942 AA 39 37-51  AG 40 36-43  GG 41 32-46 0.878 
23 rs2894420 AA 43 39-49  AG 39 36-42  GG 37 36-48 0.470 
26 rs4714211 GG 36 33-39  AG 40 37-45  AA 41 37-44 0.244 
27 rs10305525 -- -- --  CA 37 36-41  CC 40 36-45 0.369 
28 rs9296291 CC 37 37-39  TC 40 35-45  TT 41 37-43 0.812 
29 rs9968886 -- -- --  GA 37 36-45  GG 41 36-43 0.543 
30 rs2143733 GG 37 37-48  GT 39 35-43  TT 42 39-48 0.549 
31 rs9296292 CC 37 34-38  CT 39 34-44  TT 41 38-45 0.166 
Values are minutes. *Significantly faster than other two genotypes (P < 0.01). †Significantly slower than other two genotypes (P 
< 0.05). 
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Table 4. Gastric emptying T½ results according to genotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SNP ID 
Homozygous Minor Allele  Heterozygous  Homozygous Major Allele P-value 
Genotype Median Quartiles  Genotype Median Quartiles  Genotype Median Quartiles  
1 rs7738586 --- -- --  CA 62 56-72  CC 64 55-79 0.919 
2 rs9380825 AA 71 61-80  AG 64 56-80     GG 60 55-70 0.650 
4 rs926674 TT 59 56-62  TC 60 55-71  CC 64 56-82 0.569 
5 rs2268657 GG 72 59-83  AG 61 56-73  AA 59 53-67 0.203 
6 rs13202369 GG 70 58-81  AG 62 54-77  AA 64 56-73 0.935 
7 rs3799707 TT 61 57-66  GT 59 54-83  GG 66 59-78 0.452 
8 rs10305432 CC 59 56-71  CT 65 57-75  TT 62 55-80 0.852 
9 rs9283907 AA 41 41-41  AG 56 54-62  GG 67 59-82 0.054 
10 rs742764 CC 54 53-59  TC 66 56-80  TT 66 59-81 0.061 
11 rs2254336 TT 59 53-68  TA 62 54-75  AA 71 62-85 0.138 
12 rs910163 CC 59 56-60  TC 66 54-82  TT 62 57-73 0.431 
14 rs6923761 AA 72 66-81  GA 62 56-74  GG 59 54-83 0.297 
15 rs7766663 GG 57 53-66  GT 62 54-79  TT 71 61-81 0.168 
16 rs932443 GG 60 59-68  AG 65 54-83  AA 62 57-72 0.820 
17 rs2268646 -- -- --  AG 67 57-87  GG 63 54-76 0.485 
18 rs2300614 TT 54 53-59  CT 65 54-83  CC 66 58-73 0.120 
19 rs2268641 AA 57 54-59  AG 65 54-80  GG 63 58-73 0.283 
20 rs2268640 CC 59 56-60  TC 66 54-82  TT 62 57-73 0.453 
21 rs2268639 TT 59 56-60  TA 65 55-79  AA 63 56-73 0.475 
22 rs2206942 AA 60 57-86  AG 65 55-78  GG 63 55-73 0.959 
23 rs2894420 AA 72 64-92  AG 62 55-72  GG 59 54-81 0.187 
26 rs4714211 GG 54 54-60  AG 64 56-75  AA 68 59-89 0.233 
27 rs10305525 -- -- --  CA 59 55-68  CC 64 55-79 0.412 
28 rs9296291 CC 59 56-60  TC 66 54-83  TT 62 56-72 0.386 
29 rs9968886 -- -- --  GA 61 56-92  GG 65 54-74 0.934 
30 rs2143733 GG 59 55-77  GT 64 55-79  TT 65 59-73 0.791 
31 rs9296292 CC 56 52-59  CT 65 54-81  TT 66 60-77 0.125 
Values are minutes. 
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Table 5. Gastric emptying Tlag results according to phenotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SNP ID 
Homozygous Major Allele  Heterozygous/homozygous Minor Allele P-value 
Phenotype n Median Quartiles  Phenotype n Median Quartiles  
1 rs7738586 CC 38 40 37-45  A 10 37 34-41 0.274 
2 rs9380825 GG 15 37 36-40  A 33 41 37-44 0.157 
4 rs926674 CC 39 41 36-46  T 9 37 36-40 0.239 
5 rs2268657 AA 11 37* 34-39  G 36 41 37-45 0.028 
6 rs13202369 AA 25 39 36-42  G 23 41 36-48 0.627 
7 rs3799707 GG 26 40 37-45  T 22 40 34-43 0.396 
8 rs10305432 TT 26 40 35-46  C 22 41 37-42 0.844 
9 rs9283907 GG 38 41 37-44  A 10 36 33-41 0.137 
10 rs742764 TT 14 41 37-46  C 33 40 35-43 0.492 
11 rs2254336 AA 16 43 39-49  T 32 39* 34-41 0.012 
12 rs910163 TT 27 41 36-44  C 21 39 36-44 0.950 
14 rs6923761 GG 13 37 34-41  A 35 40 37-44 0.197 
15 rs7766663 TT 15 42 37-48  G 33 39 35-42 0.136 
16 rs932443 AA 22 41 35-44  G 26 40 36-44 0.983 
17 rs2268646 GG 38 40 35-43  A 10 40 37-48 0.493 
18 rs2300614 CC 22 42 36-46  T 26 39 35-42 0.330 
19 rs2268641 GG 22 41 35-44  A 25 39 36-42 0.856 
20 rs2268640 TT 27 41 37-44  C 21 39 35-44 0.546 
21 rs2268639 AA 22 41 36-44  T 25 39 35-42 0.701 
22 rs2206942 GG 18 41 32-46  A 30 40 36-44 0.806 
23 rs2894420 GG 11 37 36-48  A 36 40 36-43 0.930 
26 rs4714211 AA 13 41 37-44  G 34 40 35-44 0.497 
27 rs10305525 CC 39 40 36-45  A 9 37 36-41 0.369 
28 rs9296291 TT 28 41 37-43  C 20 40 35-44 0.908 
29 rs9968886 GG 36 41 36-43  A 12 37 36-45 0.543 
30 rs2143733 TT 14 42 39-48  G 34 39 35-44 0.276 
31 rs9296292 TT 24 41 38-45  C 24 38 34-43 0.107 
Values are minutes. *Significantly faster emptying rate compared to other phenotype (P < 0.05). 
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Table 6. Gastric emptying T½ results according to phenotype. 
 
  
  
SNP ID 
          
Phenotype n Median Quartiles  Phenotype n Median Quartiles P-value 
1 rs7738586 CC 38 64 55-79  A 10 62 56-72 0.919 
2 rs9380825 GG 15 60 55-70  A 33 64 56-80 0.367 
4 rs926674 CC 39 64 56-82  T 9 59 54-65 0.355 
5 rs2268657 AA 11 59 53-67  G 36 64 56-78 0.119 
6 rs13202369 AA 25 64 56-73  G 23 62 54-80 0.757 
7 rs3799707 GG 26 66 59-78  T 22 60 54-76 0.218 
8 rs10305432 TT 26 62 55-80  C 22 65 55-76 0.836 
9 rs9283907 GG 38 67 59-82  A 10 55* 53-61 0.033 
10 rs742764 TT 14 66 59-81  C 33 62 54-77 0.478 
11 rs2254336 AA 16 71 62-85  T 32 60 54-74 0.055 
12 rs910163 TT 27 62 57-73  C 21 64 54-80 0.950 
14 rs6923761 GG 13 59 54-83  A 35 64 57-75 0.516 
15 rs7766663 TT 15 71 61-81  G 33 61 54-77 0.097 
16 rs932443 AA 22 62 57-72  G 26 65 54-82 0.702 
17 rs2268646 GG 38 63 54-76  A 10 67 57-87 0.485 
18 rs2300614 CC 22 66 58-73  T 26 62 54-79 0.521 
19 rs2268641 GG 22 63 58-73  A 25 62 54-77 0.733 
20 rs2268640 TT 27 62 57-73  C 21 64 54-80 0.755 
21 rs2268639 AA 22 65 55-79  T 25 62 54-77 0.806 
22 rs2206942 GG 18 63 55-73  A 30 63 55-79 0.774 
23 rs2894420 GG 11 59 54-81  A 36 64 56-74 0.715 
26 rs4714211 AA 13 68 59-89  G 34 62 54-73 0.385 
27 rs10305525 CC 39 64 55-79  A 9 59 55-68 0.412 
28 rs9296291 TT 28 62 56-72  C 20 65 54-81 0.875 
29 rs9968886 GG 36 65 54-74  A 12 61 56-92 0.934 
30 rs2143733 TT 14 65 59-73  G 34 63 54-79 0.691 
31 rs9296292 TT 24 66 60-77  C 24 60 54-78 0.239 
Values are minutes. *Significantly faster emptying rate compared to other phenotype (P < 0.05). 
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